iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
80.91%
Change (1 year)
Categories
iBio (IBIO) - Net assets
Net assets on the balance sheet as of December 2023 : $9.19 M
According to iBio's latest financial reports the company has $9.19 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
iBio - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-06-30 | $15.38 M | -75.77% |
| 2022-06-30 | $63.48 M | -41.53% |
| 2021-06-30 | $0.10 B | 91.79% |
| 2020-06-30 | $56.6 M | 2203.91% |
| 2019-06-30 | $2.45 M | -84.8% |
| 2018-06-30 | $16.16 M | 81.31% |
| 2017-06-30 | $8.91 M | -62.92% |
| 2016-06-30 | $24.04 M | 114.09% |
| 2015-06-30 | $11.23 M | 84.14% |
| 2014-06-30 | $6.09 M | 20.34% |
| 2013-06-30 | $5.06 M | -17.85% |
| 2012-06-30 | $6.16 M | 3037.17% |
| 2011-06-30 | $0.19 M | -81.73% |
| 2010-06-30 | $1.07 M | -75.48% |
| 2009-06-30 | $4.38 M | -170.75% |
| 2008-06-30 | $-6.21 M | 43.14% |
| 2007-06-30 | $-4.34 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 747,687.32% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $12.38 M | 34.66% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.13 B | 1,324.24% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | 6,959.91% | 🇺🇸 USA |